Collaborators

__________________________________________________________________________________________________________________________________

 

 

Dr. Josue Bautista Arteaga

President, Mexican Pharmacovigilance Association

Pharmaceutical Chemist with 15 years of experience in the pharmaceutical sector. He holds a degree in Pharmaceutical Administration. President of the Mexican Pharmacovigilance Association. Since 2006, he has played several roles across the Pharmaceutical Industry in areas such as Quality Control, Quality Assurance, and Medical Information, but since 2011 he has been working in Pharmacovigilance for Wyeth, GlaxoSmithKline and Merck Sharp & Dohme, and Pfizer, on the recent role he was responsible for the PV operations for the AMER region ( CAN, USA and LATAM) as  Senior Director.    

 

          

Dr. Irene Rina Fermont

Chairman, Eranim Israel.

Irene-Rina Fermont,the chairperson of Eranim Israel,  is a Physician and immune-hematologist. She had done her MSc in Bioengineering at Ecole Centrale Paris. She had set up and managed bone marrow graft and hemovigilance units in Yvelines Blood Bank.  Dr. Irene is having 25 years of experience in Pharmacovigilance at the global level. She was the Founder and Director of IFC Ltd Strategic Safety Consulting,  France, UK, Israel. Currently, She is the Founder and Chair of ISOP ISRAEL.

   

Dr. Gareth Dyke

Content Director

Dr. Gareth Dyke is currently holds the position of Content Director at Research Square (Springer Nature). Formerly he was associated with Edanz (edanz.com) as author education manager. He has a Ph.D. in geology from the University of Bristol and has worked for more than 15 years as a full-time academic. Dr. Dyke has published more than 290 peer-reviewed academic articles, including in Nature and Science. He has been the Editor in Chief of the Taylor & Francis journal Historical Biology for more than 17 years.

       

Arshia Bhandari

Founder PhVFIT

Arshia Bhandari is seasoned pharmacovigilance professional with 16 + years of extensive experience in operational management, client coordination, training, and mentoring in the domain of Pharmacovigilance, with experience and exposure in ICSR management, CSR narrative writing, and Aggregate reporting. Conceptualized and established processes for outsourced projects. She has coached and mentored employees in the field of PV, with a proven track record of preparing employees for a journey of quality delivery and growth. Founded PhVFit, an organization that works towards bringing holistic awareness regarding patient safety principles and pharmacovigilance through open dialogues in different forums.

 
 
 
Paúl Alfonzo Pérez Vásquez, Pharm D. Msc.
 
Presidente Fundador de la Sociedad Peruana de Farmacovigilancia (SOPERFAR)

Pharmacovigilance Specialist with experience in the Pharmaceutical Industry and the Healthcare Sector. He holds a Master's Degree in Pharmacology and is a Doctorate Candidate in Pharmacology from the Autonomous University of Barcelona - Spain. Founder President of the Peruvian Society of Pharmacovigilance (SOPERFAR). He has been working in Pharmacovigilance for the Peruvian Social Security (EsSalud), as a PV Consultant for different companies, and currently, He is working as a PV Advisor at Hersil. Also, He is an Undergraduate and Postgraduate Professor in Pharmacology/Pharmacovigilance and a Speaker on Patient Safety Issues.
 

 

Raj Vaghela

President & CEO, PubHive Ltd.

Raj Vaghela is the Founder, President and CEO at PubHive, Ltd., creators of PubHive Navigator – a scientific software platform for pharmacovigilance literature workflows . Mr. Vaghela has 20 years of leadership experience in life science software for pharmacovigilance, drug safety, medical affairs, regulatory affairs, publication planning, and R&D. He has a master’s degree in Information Technology from Vancouver University Worldwide, a bachelor’s degree in engineering from Gujarat University in India, is ITIL® certified, and ISO-certified as a lead implementer. Mr. Vaghela earned notable distinction for exceptional performance from Massachusetts Institute of Technology (MIT) in the Artificial Intelligence: Implications for Business Strategy executive management program and is fully licensed by the Pharmaceutical Information & Pharmacovigilance Association (PIPA) GVP Modules I-XV.